Ruel Garcia
Gastroenterology · Los Gatos
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- 32
- 8 carriers
- Office
- 1
On the public record
- Owns National Ambulatory Surgery Center, LLC.: Accreditation Revoked
Offices
1 location · Genesis Healthcare Partners PC · 232 clinicians in this group
Looking this up.
Hospitals listed: El Camino Health · Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
32 plans · 8 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Ruel Garcia’s office at (408) 345-5925 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
32 of 32 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G79067 · Current
Licensed to practise in California · since 1994 · expires 2027-07-31 · University of California, San Diego School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- National Ambulatory Surgery Center, LLC.Ambulatory Surgery Center · Los Angeles, CA22% owner since 2024 · accredited by AAAHCAccreditation Revoked2 inspections, 1 with deficiencies · last 2025-07-30
- Montpelier Surgery Center, IncAmbulatory Surgery Center · San Jose, CA13% owner since 2004 · accredited by AAAHCAccreditation Renewed3 inspections · last 2023-05-25
- National Ambulatory Surgery Center LLCAmbulatory Surgery Center · Los Angeles, CA16.4% owner since 2025 · accredited by AAAASFInitial Accreditation1 inspection, 1 with deficiencies · last 2025-10-07
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$61,519
Medicare paid this office $61,519 for 192 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 22 | $10,190 | $45 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 39 | $9,230 | $237 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 22 | $7,572 | $56 |
| Return visit (30+ min) | 40 | $5,768 | $111 |
| New patient visit (45+ min) | 28 | $3,621 | $129 |
See all 12 services
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 22 | $10,190 | $45 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 39 | $9,230 | $237 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 22 | $7,572 | $56 |
| Return visit (30+ min) | 40 | $5,768 | $111 |
| New patient visit (45+ min) | 28 | $3,621 | $129 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 48 | $3,602 | $74 |
| Biopsy of large bowel using a flexible endoscope | 38 | $3,462 | $91 |
| Short return visit (20+ min) | 40 | $3,347 | $78 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 11 | $2,256 | $205 |
| New patient visit (15+ min) | 17 | $921 | $54 |
| Short return visit | 11 | $502 | $46 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 13 | $194 | $15 |
Procedures Medicare counted
| Colonoscopy | 33 | More than 55% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 78 | More than 72% of doctors who do this |
Who their Medicare patients are
192 Original Medicare patients in 2024. Average age 72 · Under 65 10% · 85 and older 7% · Women 56% · Also on Medicaid 31% · Health risk score 1.33. At or below the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 75% · Diabetes 42% · Coronary heart disease 31% · Chronic kidney disease 27% · Atrial fibrillation 16% · Depression 16% · Cancer 15% · Heart failure 13% · COPD 12% · Stroke 7% · Dementia 6%.
The office billed $364,330, Medicare allowed $79,795 and paid $61,519; for 763 services of 36 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 192 | 763 | 72 | 1.33 | $364,330 | $61,519 |
| 2023 | 258 | 889 | 73 | 1.56 | $439,931 | $78,508 |
| 2022 | 305 | 997 | 73 | 1.63 | $328,555 | $85,143 |
| 2021 | 372 | 971 | 74 | 1.96 | $332,759 | $105,134 |
| 2020 | 325 | 776 | 74 | 2.18 | $310,664 | $95,013 |
| 2019 | 378 | 901 | 74 | 2.24 | $276,371 | $103,027 |
| 2018 | 429 | 1,121 | 74 | 2.30 | $328,464 | $122,566 |
| 2017 | 420 | 1,393 | 72 | 1.96 | $401,188 | $134,743 |
| 2016 | 437 | 1,352 | 72 | 1.84 | $505,714 | $149,224 |
| 2015 | 355 | 1,215 | 72 | 1.88 | $447,466 | $133,751 |
| 2014 | 417 | 1,486 | 73 | 1.74 | $471,420 | $157,992 |
| 2013 | 486 | 1,646 | 73 | 1.72 | $401,855 | $187,777 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 16 services
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 22 | $11,727 | $45 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 44 | $10,005 | $227 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 22 | $8,581 | $57 |
| New patient visit (45+ min) | 42 | $6,390 | $152 |
| Return visit (30+ min) | 42 | $6,142 | $106 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 59 | $5,097 | $85 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 17 | $3,300 | $194 |
| Biopsy of large bowel using a flexible endoscope | 33 | $3,146 | $95 |
| Short return visit (20+ min) | 27 | $2,348 | $87 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,346 | $147 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 11 | $2,267 | $206 |
| New patient visit (15+ min) | 27 | $1,416 | $52 |
| New patient visit (30+ min) | 15 | $1,284 | $86 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $940 | $85 |
| Short return visit | 12 | $666 | $56 |
| Measurement of liver stiffness | 13 | $445 | $30 |
2022: 14 services
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 19 | $12,073 | $46 |
| New patient visit (45+ min) | 92 | $11,627 | $126 |
| Return visit (30+ min) | 65 | $10,013 | $111 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 19 | $9,150 | $59 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 40 | $8,920 | $223 |
| Short return visit (20+ min) | 49 | $4,414 | $75 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 17 | $3,366 | $198 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 41 | $3,152 | $77 |
| Biopsy of large bowel using a flexible endoscope | 28 | $2,918 | $104 |
| New patient visit (30+ min) | 32 | $2,725 | $85 |
| New patient visit (15+ min) | 25 | $1,144 | $46 |
| Short return visit | 13 | $662 | $47 |
| Measurement of liver stiffness | 11 | $355 | $32 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 37 | $160 | $4 |
2021: 15 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 101 | $18,676 | $180 |
| Return visit (30+ min) | 95 | $12,404 | $104 |
| Biopsy of large bowel using a flexible endoscope | 58 | $7,175 | $124 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 30 | $6,920 | $231 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 71 | $6,355 | $90 |
| New patient visit (45+ min) | 43 | $6,011 | $140 |
| Short return visit (20+ min) | 57 | $5,365 | $81 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 16 | $4,064 | $36 |
| New patient visit (30+ min) | 41 | $3,633 | $89 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 16 | $2,810 | $40 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 16 | $2,374 | $148 |
| Diagnostic exam of large bowel using a flexible endoscope | 16 | $2,296 | $143 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 11 | $2,142 | $195 |
| New patient visit (15+ min) | 19 | $1,295 | $68 |
| Measurement of liver stiffness | 15 | $443 | $30 |
2020: 15 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 97 | $18,487 | $185 |
| Return visit (30+ min) | 95 | $12,862 | $98 |
| New patient visit (45+ min) | 68 | $9,081 | $134 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 29 | $6,800 | $234 |
| Biopsy of large bowel using a flexible endoscope | 40 | $4,168 | $104 |
| Short return visit (20+ min) | 55 | $4,136 | $68 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 49 | $3,877 | $79 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 22 | $3,538 | $147 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 24 | $2,906 | $97 |
| Diagnostic exam of large bowel using a flexible endoscope | 13 | $2,093 | $161 |
| New patient visit (30+ min) | 23 | $1,511 | $66 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 13 | $1,044 | $80 |
| Short return visit | 13 | $588 | $45 |
| Measurement of liver stiffness | 11 | $390 | $35 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 43 | $189 | $4 |
2019: 17 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 118 | $21,344 | $179 |
| Return visit (30+ min) | 90 | $11,410 | $94 |
| New patient visit (45+ min) | 71 | $9,508 | $134 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 30 | $7,049 | $235 |
| Short return visit (20+ min) | 66 | $4,687 | $65 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 49 | $3,653 | $75 |
| Diagnostic exam of large bowel using a flexible endoscope | 20 | $3,156 | $158 |
| Biopsy of large bowel using a flexible endoscope | 28 | $3,147 | $112 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 20 | $3,046 | $152 |
| New patient visit (30+ min) | 37 | $2,926 | $79 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 14 | $2,879 | $206 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 25 | $2,808 | $94 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $2,416 | $201 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 20 | $1,939 | $97 |
| Measurement of liver stiffness | 28 | $1,033 | $37 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $618 | $52 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 74 | $338 | $5 |
2018: 20 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 109 | $20,739 | $182 |
| New patient visit (45+ min) | 116 | $15,465 | $133 |
| Return visit (30+ min) | 98 | $14,001 | $95 |
| Biopsy of large bowel using a flexible endoscope | 61 | $8,938 | $147 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 55 | $5,308 | $95 |
| Short return visit (20+ min) | 67 | $4,694 | $61 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 18 | $4,451 | $234 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 29 | $3,756 | $92 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 18 | $3,722 | $207 |
| Diagnostic exam of large bowel using a flexible endoscope | 20 | $2,849 | $142 |
| New patient visit (30+ min) | 39 | $2,814 | $72 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 13 | $2,763 | $213 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 13 | $2,515 | $180 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 17 | $2,201 | $129 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 16 | $1,597 | $94 |
| Measurement of liver stiffness | 28 | $1,188 | $41 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $1,111 | $65 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $528 | $48 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 119 | $528 | $4 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 32 | $347 | $10 |
2017: 25 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 94 | $17,948 | $181 |
| Return visit (30+ min) | 89 | $10,781 | $97 |
| Biopsy of large bowel using a flexible endoscope | 68 | $10,390 | $153 |
| New patient visit (45+ min) | 69 | $9,859 | $143 |
| Short return visit (20+ min) | 114 | $8,693 | $61 |
| Pathology examination of tissue using a microscope, intermediate complexity | 59 | $7,367 | $67 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 76 | $6,952 | $88 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 26 | $5,310 | $204 |
| New patient visit (30+ min) | 57 | $5,096 | $89 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 21 | $4,913 | $234 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 26 | $4,494 | $173 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 38 | $4,207 | $93 |
| Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | 11 | $3,393 | $308 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 15 | $3,182 | $212 |
| Special stained specimen slides to identify organisms including interpretation and report | 24 | $2,730 | $98 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 26 | $2,138 | $65 |
| Diagnostic exam of large bowel using a flexible endoscope | 14 | $2,039 | $146 |
| Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $1,894 | $172 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $1,310 | $101 |
| Incision of pancreatic outlet using a flexible endoscope | 13 | $1,009 | $78 |
| New patient visit (15+ min) | 15 | $783 | $52 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 66 | $731 | $10 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 41 | $518 | $11 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 101 | $514 | $5 |
| New patient visit (10+ min) | 14 | $507 | $36 |
2016: 25 services
| Biopsy of large bowel using a flexible endoscope | 104 | $15,826 | $152 |
| Pathology examination of tissue using a microscope, intermediate complexity | 125 | $15,631 | $72 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 63 | $11,287 | $176 |
| Short return visit (20+ min) | 115 | $10,197 | $67 |
| Return visit (30+ min) | 88 | $9,948 | $96 |
| New patient visit (45+ min) | 53 | $7,797 | $147 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 33 | $7,609 | $231 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 42 | $7,577 | $180 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 79 | $6,330 | $76 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 29 | $6,308 | $218 |
| New patient visit (30+ min) | 66 | $6,265 | $95 |
| Special stained specimen slides to identify organisms including interpretation and report | 42 | $4,996 | $100 |
| Complete ultrasound scan of abdomen | 27 | $3,939 | $123 |
| Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | 14 | $3,887 | $259 |
| Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 14 | $3,215 | $230 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 24 | $2,870 | $93 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 13 | $2,717 | $209 |
| Diagnostic exam of large bowel using a flexible endoscope | 14 | $2,219 | $159 |
| Limited ultrasound scan of abdomen | 18 | $1,976 | $90 |
| New patient visit (15+ min) | 23 | $1,489 | $65 |
| New patient visit (10+ min) | 35 | $1,201 | $34 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $1,180 | $107 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $1,157 | $64 |
| Incision of pancreatic outlet using a flexible endoscope | 14 | $1,081 | $72 |
| Measurement of liver stiffness | 18 | $561 | $31 |
2015: 22 services
| Biopsy of large bowel using a flexible endoscope | 83 | $14,720 | $173 |
| Pathology examination of tissue using a microscope, intermediate complexity | 98 | $12,284 | $58 |
| Return visit (30+ min) | 93 | $11,935 | $95 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 42 | $10,824 | $258 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 42 | $7,667 | $178 |
| New patient visit (45+ min) | 49 | $7,113 | $145 |
| Short return visit (20+ min) | 82 | $6,693 | $66 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 37 | $6,406 | $173 |
| New patient visit (30+ min) | 62 | $5,781 | $93 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 74 | $5,448 | $73 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 22 | $4,886 | $222 |
| Special stained specimen slides to identify organisms including interpretation and report | 33 | $4,300 | $90 |
| Diagnostic exam of large bowel using a flexible endoscope | 14 | $2,575 | $172 |
| Limited ultrasound scan of abdomen | 19 | $2,334 | $90 |
| Complete ultrasound scan of abdomen | 15 | $2,077 | $122 |
| New patient visit (15+ min) | 25 | $1,607 | $64 |
| Special stained specimen slides to examine tissue including interpretation and report | 14 | $1,239 | $59 |
| New patient visit (10+ min) | 31 | $1,160 | $37 |
| Special stained specimen slides to examine tissue, initial procedure | 11 | $1,066 | $89 |
| Measurement of liver stiffness | 26 | $913 | $34 |
| Injection beneath lining of large bowel using a flexible endoscope | 13 | $520 | $40 |
| Incision of pancreatic outlet using a flexible endoscope | 11 | $343 | $31 |
2014: 24 services
| Return visit (30+ min) | 116 | $15,768 | $96 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 45 | $12,073 | $268 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 64 | $11,692 | $180 |
| Biopsy of large bowel using a flexible endoscope | 72 | $10,897 | $151 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 47 | $8,344 | $164 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 35 | $8,309 | $237 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 95 | $8,148 | $80 |
| Short return visit (20+ min) | 96 | $8,021 | $67 |
| Pathology examination of tissue using a microscope, intermediate complexity | 104 | $7,562 | $33 |
| New patient visit (45+ min) | 49 | $7,125 | $145 |
| New patient visit (30+ min) | 68 | $6,205 | $91 |
| Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | 22 | $5,848 | $244 |
| Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 17 | $4,237 | $212 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 28 | $3,882 | $92 |
| Special stained specimen slides to examine tissue including interpretation and report | 46 | $3,784 | $54 |
| Special stained specimen slides to identify organisms including interpretation and report | 45 | $3,659 | $69 |
| Complete ultrasound scan of abdomen | 22 | $3,273 | $142 |
| Limited ultrasound scan of abdomen | 23 | $3,112 | $94 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 34 | $2,754 | $64 |
| Diagnostic exam of large bowel using a flexible endoscope | 13 | $2,490 | $192 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $1,312 | $109 |
| New patient visit (15+ min) | 19 | $1,258 | $66 |
| New patient visit (10+ min) | 26 | $987 | $38 |
| Incision of pancreatic outlet using a flexible endoscope | 19 | $923 | $49 |
2013: 23 services
| Return visit (30+ min) | 134 | $17,338 | $96 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 63 | $16,695 | $242 |
| Biopsy of large bowel using a flexible endoscope | 84 | $13,065 | $154 |
| New patient visit (45+ min) | 89 | $13,011 | $146 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 48 | $12,788 | $266 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 69 | $12,506 | $176 |
| Short return visit (20+ min) | 110 | $10,682 | $66 |
| Pathology examination of tissue using a microscope, intermediate complexity | 111 | $9,596 | $35 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 103 | $9,172 | $87 |
| Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 23 | $8,836 | $368 |
| Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | 14 | $7,856 | $436 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 27 | $6,419 | $238 |
| New patient visit (30+ min) | 61 | $5,675 | $93 |
| Complete ultrasound scan of abdomen | 27 | $4,043 | $139 |
| Limited ultrasound scan of abdomen | 26 | $3,794 | $100 |
| Special stained specimen slides to examine tissue including interpretation and report | 45 | $3,453 | $59 |
| Special stained specimen slides to identify organisms including interpretation and report | 44 | $3,435 | $75 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 41 | $3,318 | $63 |
| Diagnostic exam of large bowel using a flexible endoscope | 18 | $3,188 | $177 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $2,265 | $91 |
| New patient visit (15+ min) | 24 | $1,624 | $68 |
| Incision of pancreatic outlet using a flexible endoscope | 13 | $1,621 | $116 |
| New patient visit (10+ min) | 33 | $1,310 | $40 |
Medicaid work
$439 in 2023
Medicaid paid $439 for 25 billed services this clinician did in 2023, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Upper gastrointestinal endoscopy with biopsy | 13 | $423 |
| Return visit (30+ min) | 12 | $16 |
| 2023 | 25 | 2 | 13 | $439 |
| 2022 | 41 | 2 | 16 | $76 |
| 2021 | 204 | 4 | 19 | $3,093 |
| 2020 | 76 | 2 | 19 | $1,586 |
| 2019 | 125 | 3 | 24 | $3,147 |
| 2018 | 217 | 4 | 19 | $2,177 |
See the largest Medicaid services in earlier years
2022
| New patient visit (45+ min) | 13 | $76 |
| Short return visit (20+ min) | 28 | $0 |
2021
| 1ST HOSP IP/OBS HIGH 75 | 79 | $2,534 |
| Upper gastrointestinal endoscopy with biopsy | 24 | $356 |
| Return visit (30+ min) | 87 | $203 |
| Short return visit (20+ min) | 14 | $0 |
2020
| 1ST HOSP IP/OBS HIGH 75 | 50 | $1,545 |
| Return visit (30+ min) | 26 | $41 |
2019
| 1ST HOSP IP/OBS HIGH 75 | 87 | $2,813 |
| New patient visit (45+ min) | 12 | $212 |
| Return visit (30+ min) | 26 | $122 |
2018
| 1ST HOSP IP/OBS HIGH 75 | 88 | $2,012 |
| Return visit (30+ min) | 91 | $165 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 12 | $0 |
| New patient visit (45+ min) | 26 | $0 |
Drugs they prescribed that Part D paid
$36,297
Pharmacies billed $36,297 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 252) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
209 generic and 43 brand-name prescriptions · $36,297 in drug cost · 12 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Vemlidy | 13 | $18,511 | $1,424 |
| Entecavir | 17 | $5,141 | $302 |
| Gavilyte-G | 45 | $597 | $13 |
| Omeprazole | 34 | $586 | $17 |
| Peg 3350-Electrolyte | 16 | $294 | $18 |
See all 8 drugs
| Vemlidy | 13 | $18,511 | $1,424 |
| Entecavir | 17 | $5,141 | $302 |
| Gavilyte-G | 45 | $597 | $13 |
| Omeprazole | 34 | $586 | $17 |
| Peg 3350-Electrolyte | 16 | $294 | $18 |
| Peg-3350 and Electrolytes | 18 | $235 | $13 |
| Spironolactone | 18 | $109 | $6 |
| Pantoprazole | 12 | $108 | $9 |
Year by year
| 2024 | 252 | 140 | 0% (0) | 17% | $36,297 |
| 2023 | 388 | 196 | 0% (0) | 16% | $242,351 |
| 2022 | 549 | 273 | None | 34% | $124,154 |
| 2021 | 647 | 284 | 0% (0) | 44% | $165,986 |
| 2020 | 650 | 241 | None | 34% | $214,718 |
| 2019 | 704 | 296 | 0% (0) | 34% | $308,095 |
| 2018 | 694 | 308 | 0% (0) | 33% | $634,715 |
| 2017 | 646 | 313 | 0% (0) | 49% | $738,465 |
| 2016 | 693 | 324 | 0% (0) | 48% | $1,326,881 |
| 2015 | 618 | 310 | None | 52% | $980,464 |
| 2014 | 549 | 239 | None | 52% | $675,791 |
| 2013 | 600 | 273 | None | 56% | $152,776 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 9 drugs
| Vemlidy | 24 | $36,084 | $1,503 |
| Entecavir | 34 | $3,314 | $97 |
| Gavilyte-G | 99 | $1,780 | $18 |
| Mercaptopurine | 13 | $1,192 | $92 |
| Omeprazole | 45 | $1,016 | $23 |
| Pantoprazole | 33 | $819 | $25 |
| Peg-3350 and Electrolytes | 13 | $240 | $18 |
| Spironolactone | 21 | $120 | $6 |
| Furosemide | 17 | $93 | $5 |
2022: 14 drugs
| Vemlidy | 70 | $93,215 | $1,332 |
| Entecavir | 46 | $4,668 | $101 |
| Plenvu | 11 | $1,542 | $140 |
| Suprep | 11 | $1,250 | $114 |
| Mercaptopurine | 13 | $1,155 | $89 |
| Peg-3350 and Electrolytes | 72 | $1,116 | $15 |
| Gavilyte-G | 76 | $1,041 | $14 |
| Pantoprazole | 38 | $772 | $20 |
| Omeprazole | 56 | $560 | $10 |
| Peg 3350-Electrolyte | 14 | $265 | $19 |
| Gavilyte-C | 16 | $260 | $16 |
| Sulfasalazine | 11 | $118 | $11 |
| Spironolactone | 12 | $111 | $9 |
| Furosemide | 13 | $97 | $7 |
2021: 16 drugs
| Vemlidy | 72 | $89,245 | $1,240 |
| Mesalamine | 22 | $13,922 | $633 |
| Suprep | 122 | $13,187 | $108 |
| Entecavir | 56 | $9,096 | $162 |
| Linzess | 11 | $6,174 | $561 |
| Ursodiol | 11 | $1,648 | $150 |
| Mercaptopurine | 15 | $1,509 | $101 |
| Tenofovir Disoproxil | 15 | $612 | $41 |
| Omeprazole | 64 | $568 | $9 |
| Peg-3350 and Electrolytes | 35 | $454 | $13 |
| Peg 3350-Electrolyte | 21 | $385 | $18 |
| Pantoprazole | 36 | $345 | $10 |
| Gavilyte-G | 27 | $344 | $13 |
| Ondansetron | 18 | $137 | $8 |
| Spironolactone | 14 | $133 | $9 |
| Furosemide | 12 | $95 | $8 |
2020: 16 drugs
| Vemlidy | 87 | $103,097 | $1,185 |
| Entecavir | 61 | $14,135 | $232 |
| Mesalamine | 11 | $11,417 | $1,038 |
| Suprep | 48 | $4,986 | $104 |
| Ursodiol | 14 | $1,984 | $142 |
| Mercaptopurine | 16 | $1,444 | $90 |
| Gavilyte-G | 70 | $973 | $14 |
| Omeprazole | 95 | $741 | $8 |
| Lactulose | 11 | $470 | $43 |
| Peg-3350 and Electrolytes | 30 | $370 | $12 |
| Tenofovir Disoproxil | 13 | $357 | $27 |
| Pantoprazole | 28 | $253 | $9 |
| Dicyclomine | 12 | $153 | $13 |
| Levofloxacin | 11 | $69 | $6 |
| Spironolactone | 11 | $60 | $5 |
| Furosemide | 12 | $55 | $5 |
2019: 17 drugs
| Vemlidy | 80 | $90,006 | $1,125 |
| Creon | 21 | $57,027 | $2,716 |
| Entecavir | 51 | $20,026 | $393 |
| Mesalamine | 14 | $13,198 | $943 |
| Apriso | 13 | $7,495 | $577 |
| Ursodiol | 19 | $4,447 | $234 |
| Tenofovir Disoproxil | 26 | $3,874 | $149 |
| Suprep | 30 | $2,945 | $98 |
| Gavilyte-G | 142 | $2,127 | $15 |
| Mercaptopurine | 16 | $1,370 | $86 |
| Omeprazole | 82 | $1,283 | $16 |
| Peg-3350 and Electrolytes | 29 | $351 | $12 |
| Pantoprazole | 26 | $341 | $13 |
| Peg 3350-Electrolyte | 16 | $245 | $15 |
| Dicyclomine | 19 | $230 | $12 |
| Spironolactone | 18 | $137 | $8 |
| Furosemide | 11 | $47 | $4 |
2018: 18 drugs
| Harvoni | 12 | $380,666 | $31,722 |
| Vemlidy | 58 | $62,757 | $1,082 |
| Creon | 12 | $32,164 | $2,680 |
| Entecavir | 41 | $27,446 | $669 |
| Asacol Hd | 15 | $11,740 | $783 |
| Apriso | 12 | $5,669 | $472 |
| Tenofovir Disoproxil | 18 | $4,911 | $273 |
| Gavilyte-G | 132 | $1,836 | $14 |
| Mercaptopurine | 12 | $1,318 | $110 |
| Omeprazole | 92 | $1,118 | $12 |
| Suprep | 11 | $1,022 | $93 |
| Peg 3350-Electrolyte | 36 | $700 | $19 |
| Peg-3350 and Electrolytes | 53 | $671 | $13 |
| Propranolol | 12 | $569 | $47 |
| Spironolactone | 13 | $249 | $19 |
| Pantoprazole | 30 | $233 | $8 |
| Dicyclomine | 16 | $174 | $11 |
| Furosemide | 12 | $127 | $11 |
2017: 15 drugs
| Epclusa | 13 | $331,770 | $25,521 |
| Vemlidy | 65 | $66,639 | $1,025 |
| Entecavir | 45 | $30,295 | $673 |
| Creon | 12 | $30,223 | $2,519 |
| Viread | 28 | $23,627 | $844 |
| Asacol Hd | 13 | $9,354 | $720 |
| Peg 3350-Electrolyte | 98 | $1,646 | $17 |
| Gavilyte-N | 48 | $878 | $18 |
| Gavilyte-G | 47 | $663 | $14 |
| Omeprazole | 46 | $506 | $11 |
| Peg-3350 and Electrolytes | 38 | $475 | $13 |
| Propranolol | 13 | $377 | $29 |
| Dicyclomine | 31 | $169 | $5 |
| Pantoprazole | 17 | $141 | $8 |
| Furosemide | 11 | $40 | $4 |
2016: 19 drugs
| Harvoni | 21 | $673,151 | $32,055 |
| Viread | 59 | $48,290 | $818 |
| Entecavir | 54 | $38,476 | $713 |
| Baraclude | 13 | $16,365 | $1,259 |
| Lialda | 13 | $7,936 | $610 |
| Peg 3350-Electrolyte | 109 | $1,958 | $18 |
| Gavilyte-N | 60 | $1,144 | $19 |
| Omeprazole | 82 | $576 | $7 |
| Propranolol | 16 | $431 | $27 |
| Peg-3350 and Electrolytes | 28 | $368 | $13 |
| Trilyte With Flavor Packets | 12 | $229 | $19 |
| Levofloxacin | 20 | $202 | $10 |
| Gavilyte-G | 12 | $184 | $15 |
| Spironolactone | 14 | $136 | $10 |
| Amoxicillin | 16 | $131 | $8 |
| Pantoprazole | 15 | $112 | $7 |
| Peg 3350-Electrolyte | 11 | $111 | $10 |
| Dicyclomine | 11 | $55 | $5 |
| Furosemide | 14 | $53 | $4 |
2015: 15 drugs
| Harvoni | 26 | $826,138 | $31,775 |
| Viread | 48 | $37,908 | $790 |
| Entecavir | 28 | $25,097 | $896 |
| Lialda | 24 | $13,659 | $569 |
| Baraclude | 11 | $10,550 | $959 |
| Linzess | 11 | $4,316 | $392 |
| Peg 3350-Electrolyte | 103 | $1,985 | $19 |
| Mercaptopurine | 12 | $1,763 | $147 |
| Gavilyte-N | 44 | $870 | $20 |
| Omeprazole | 72 | $749 | $10 |
| Gavilyte-G | 46 | $660 | $14 |
| Peg-3350 and Electrolytes | 37 | $526 | $14 |
| Trilyte With Flavor Packets | 14 | $275 | $20 |
| Pantoprazole | 16 | $114 | $7 |
| Amoxicillin | 12 | $95 | $8 |
2014: 14 drugs
| Sovaldi | 15 | $427,814 | $28,521 |
| Baraclude | 52 | $55,258 | $1,063 |
| Pegasys Proclick | 16 | $49,525 | $3,095 |
| Viread | 36 | $29,193 | $811 |
| Lialda | 20 | $9,048 | $452 |
| Peg-3350 | 82 | $1,633 | $20 |
| Omeprazole | 85 | $1,244 | $15 |
| Gavilyte-N | 30 | $583 | $19 |
| Polyethylene Glycol 3350 | 15 | $402 | $27 |
| Peg-3350 and Electrolytes | 26 | $383 | $15 |
| Gavilyte-G | 16 | $245 | $15 |
| Trilyte With Flavor Packets | 12 | $236 | $20 |
| Pantoprazole | 19 | $128 | $7 |
| Peg 3350-Electrolyte | 11 | $123 | $11 |
2013: 12 drugs
| Baraclude | 50 | $48,966 | $979 |
| Viread | 35 | $29,708 | $849 |
| Lialda | 26 | $14,714 | $566 |
| Nexium | 16 | $3,377 | $211 |
| Peg-3350 With Flavor Packs | 125 | $2,495 | $20 |
| Omeprazole | 95 | $1,403 | $15 |
| Gavilyte-N | 29 | $596 | $21 |
| Trilyte With Flavor Packets | 20 | $428 | $21 |
| Polyethylene Glycol 3350 | 14 | $337 | $24 |
| Pantoprazole | 23 | $271 | $12 |
| Lactulose | 11 | $151 | $14 |
| Amoxicillin | 12 | $118 | $10 |
Money from drug and device companies
$2,724 in 2025
| 2025 | 11 | 51 | None | $2,724 |
| 2024 | 9 | 41 | None | $686 |
| 2023 | 10 | 27 | None | $526 |
| 2022 | 7 | 24 | None | $507 |
| 2021 | 8 | 47 | $9,404 | $10,203 |
| 2020 | 9 | 13 | $6,300 | $6,571 |
| 2019 | 5 | 38 | None | $618 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | Spyglass | $1,645 | 13 payments
|
| 3-D Matrix | None | $274 | 1 payment
|
| Abbvie | Rinvoq | $230 | 13 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $227 | 8 payments
|
| Gilead Sciences | None | $106 | 5 payments
|
| Janssen Biotech | Tremfya | $78 | 3 payments
|
See all 50 published payments
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-12-21 | Xifaxan | $20 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-11-11 | Xifaxan | $121 |
| Abbvie | Meals · 2025-11-06 | Creon | $8 |
| Boston Scientific | Meals · 2025-10-29 | Apollo Esg System | $67 |
| Gilead Sciences | Meals · 2025-10-24 | None | $24 |
| Abbvie | Meals · 2025-10-21 | Skyrizi | $24 |
| Boston Scientific | Meals · 2025-09-26 | Spyglass | $94 |
| Boston Scientific | Travel · 2025-09-26 | Spyglass | $87 |
| Boston Scientific | Meals · 2025-09-25 | Overstitch Endoscopic Suturing System | $66 |
| Boston Scientific | Meals · 2025-09-25 | Spyglass | $102 |
| Boston Scientific | Meals · 2025-09-25 | Spyglass | $94 |
| Boston Scientific | Travel · 2025-09-25 | Spyglass | $210 |
| Boston Scientific | Travel · 2025-09-25 | Spyglass | $75 |
| Boston Scientific | Meals · 2025-09-24 | Apollo Esg System | $94 |
| Boston Scientific | Travel · 2025-09-24 | Spyglass | $210 |
| Boston Scientific | Travel · 2025-09-24 | Spyglass | $275 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-09-22 | Xifaxan | $16 |
| Abbvie | Meals · 2025-09-10 | Linzess | $26 |
| Boston Scientific | Meals · 2025-09-09 | Axios | $128 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-08-25 | Xifaxan | $13 |
| Abbvie | Meals · 2025-07-30 | Rinvoq | $23 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-07-28 | Xifaxan | $22 |
| Boston Scientific | Meals · 2025-07-22 | Overstitch Endoscopic Suturing System | $144 |
| Janssen Biotech | Meals · 2025-07-15 | Tremfya | $27 |
| Gilead Sciences | Meals · 2025-07-10 | None | $17 |
| Abbvie | Meals · 2025-07-09 | Rinvoq | $26 |
| Pfizer | Meals · 2025-06-24 | Xeljanz | $16 |
| Fresenius Kabi USA | Meals · 2025-05-29 | Adalimumab-Aacf | $35 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-05-27 | Xifaxan | $8 |
| Intercept Pharmaceuticals | Meals · 2025-05-15 | Ocaliva | $30 |
| Abbvie | Meals · 2025-05-06 | Linzess | $12 |
| 3-D Matrix | Meals · 2025-05-05 | None | $274 |
| Gilead Sciences | Meals · 2025-04-30 | None | $25 |
| Abbvie | Meals · 2025-04-08 | Linzess | $11 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-03-28 | Xifaxan | $12 |
| Abbvie | Meals · 2025-03-27 | Rinvoq | $13 |
| Abbvie | Meals · 2025-03-15 | Linzess | $7 |
| Abbvie | Meals · 2025-03-12 | Rinvoq | $26 |
| Pfizer | Meals · 2025-03-12 | Xeljanz | $20 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-03-06 | Xifaxan | $15 |
| Gilead Sciences | Meals · 2025-02-27 | None | $19 |
| Janssen Biotech | Meals · 2025-02-25 | Tremfya | $26 |
| Abbvie | Meals · 2025-02-25 | Linzess | $12 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-02-13 | Entyvio | $22 |
| Pfizer | Meals · 2025-02-12 | Xeljanz | $16 |
| Abbvie | Meals · 2025-02-06 | Rinvoq | $27 |
| Janssen Biotech | Meals · 2025-01-28 | Tremfya | $25 |
| Abbvie | Meals · 2025-01-23 | Linzess | $14 |
| Gilead Sciences | Meals · 2025-01-16 | None | $21 |
| Madrigal Pharmaceuticals | Meals · 2025-01-08 | Rezdiffra | $25 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $686
| Abbvie | Mavyret | $302 | 22 payments
|
| Gilead Sciences | None | $211 | 9 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $48 | 3 payments
|
| Janssen Biotech | Stelara | $35 | 2 payments
|
| Phathom Pharmaceuticals | Voquezna | $29 | 1 payment
|
| Intercept Pharmaceuticals | Ocaliva | $22 | 1 payment
|
| Ironwood Pharmaceuticals | Linzess | $19 | 1 payment
|
| Braintree Laboratories | Suflave | $13 | 1 payment
|
| Endogastric Solutions | Esophyx | $7 | 1 payment
|
2023: $526
| Abbvie | Rinvoq | $222 | 14 payments
|
| Gilead Sciences | None | $77 | 3 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $49 | 3 payments
|
| Ardelyx | Ibsrela | $36 | 1 payment
|
| Celgene | Zeposia | $29 | 1 payment
|
| Intercept Pharmaceuticals | Ocaliva | $26 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Andexxa | $25 | 1 payment
|
| Celltrion USA | Yuflyma | $25 | 1 payment
|
| Braintree Laboratories | Suflave | $23 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $13 | 1 payment
|
2022: $507
| Abbvie | Rinvoq | $272 | 14 payments
|
| Gilead Sciences | None | $106 | 4 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $44 | 2 payments
|
| Merck Sharp & Dohme | Dificid | $24 | 1 payment
|
| Janssen Biotech | Stelara | $23 | 1 payment
|
| Ironwood Pharmaceuticals | Linzess | $22 | 1 payment
|
| RedHill Biopharma | Talicia | $15 | 1 payment
|
2021: $10,203
| CapsoVision | Capsocam Colon | $9,404 | 2 payments
|
| Gilead Sciences | None | $254 | 13 payments
|
| AbbVie | Humira | $237 | 14 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $170 | 11 payments
|
| Ironwood Pharmaceuticals | Linzess | $53 | 3 payments
|
| Braintree Laboratories | Sutab | $42 | 2 payments
|
| Nestle HealthCare Nutrition | Zenpep | $23 | 1 payment
|
| RedHill Biopharma | Talicia | $20 | 1 payment
|
2020: $6,571
| CapsoVision | None | $6,300 | 1 payment
|
| Braintree Laboratories | Suprep Bowel Prep | $61 | 3 payments
|
| AbbVie | Mavyret | $59 | 2 payments
|
| RedHill Biopharma | Talicia | $33 | 2 payments
|
| Gilead Sciences | None | $28 | 1 payment
|
| EUSA Pharma (US) | Sylvant | $25 | 1 payment
|
| Alfasigma USA | None | $23 | 1 payment
|
| Merck Sharp & Dohme | Dificid | $21 | 1 payment
|
| Coloplast | Continence Care | $21 | 1 payment
|
2019: $618
| AbbVie | Mavyret | $262 | 13 payments
|
| Shionogi | Mulpleta | $213 | 9 payments
|
| Gilead Sciences | None | $110 | 14 payments
|
| Braintree Laboratories | Suprep Bowel Prep | $19 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $14 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 84.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1790789022
- Licence
- CA G79067California G79067: Current · expires 2027-07-31
- Trained
- University of California, San Diego School of Medicine, 1992
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G79067
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 2340 Montpelier Dr, Ste A, San Jose, CA, 95116
- NPI first listed
- 2005-06-01
- NPI last updated
- 2026-07-13
This is when the NPI record was last certified, not a medical board exam.